This narrative review aims to summarize best practices in palliative care for patients undergoing evaluation for organ donation.
Background:
Palliative care clinicians are uniquely positioned to improve care for potential organ donors and their families. When ongoing life support is no longer consistent with the patient's/family's goals, inpatient palliative care clinicians should be able to recognize and advocate for the end-of-life (EOL) priorities of patients who are potential organ donors. This includes guiding communication during decision-making, as well as providing symptom management for patients and psychosocial support for patients and caregivers.
Methods:
We conducted a narrative review of published literature and policies relating to the role of palliative care in potential organ donors.
Results:
Families of organ donors report a high rate of satisfaction with the decision to pursue organ donation; however, family distress remains common. Moral distress is also common among clinicians caring for patients undergoing organ donation, which can stem from concern for under-treatment of symptoms, worries that medications for comfort are being used to hasten death, and lack of clear roles and expectations in managing the dDCD process.
Discussion:
We present strategies for supporting and communicating with patients and families prior to and during evaluation for organ donation. We also outline a framework for symptom management in the setting of potential dDCD, emphasizing that potential organ donors should always receive EOL symptom management in line with current best practices for withdrawal of life-sustaining treatments, though limited guidance exists for applying these practices in the context of anticipated dDCD. Finally, we discuss the role of palliative care in mitigating moral distress among medical teams and Organ Procurement Organization staff caring for patients who are potential organ donors.
PotterJE, PerryL, ElliottRM, COMFORT Investigators. Bereaved family members’ perspectives of their organ donation decision at 3 months post death of the donor-eligible patient in critical care: A dual-method study. Aust Crit Care2025;38(2):101132.
2.
FukunishiI, ParisW, MitchellS, et al.Posttraumatic stress disorder in the families of cadaveric and living donor population: A comparison of Japanese and American outcomes. In: Transplantation Proceedings. Grune & Stratton: Orlando, FL; 2002; p. 2627.
3.
AzoulayE, PochardF, Kentish-BarnesN, et al.; FAMIREA Study Group. Risk of post-traumatic stress symptoms in family members of intensive care unit patients. Am J Respir Crit Care Med2005;171(9):987–994.
4.
KesselringA, KainzM, KissA. Traumatic memories of relatives regarding brain death, request for organ donation and interactions with professionals in the ICU. Am J Transplant2007;7(1):211–217.
5.
SartiAJ, SutherlandS, MeadeM, et al.; Canadian Critical Care Trials Group. The experiences of family members of deceased organ donors and suggestions to improve the donation process: A qualitative study. CMAJ2022;194(30):E1054–E1061.
6.
SartiAJ, SutherlandS, HealeyA, et al.A multicenter qualitative investigation of the experiences and perspectives of substitute decision makers who underwent organ donation decisions. Prog Transplant2018;28(4):343–348.
7.
KenastonMW, BaldeoR, MurphyTK. Palliative care utilization and timing for patients undergoing solid organ transplantation in a large multicenter cohort. Transplantation2026;110(5):e1050–e1060.
8.
National Academies of Sciences E and MH and MDB on HSPC on I in ODIR. Legal, regulatory, and policy frameworks for organ donation and research participation. In: Opportunities for Organ Donor Intervention Research: Saving Lives by Improving the Quality and Quantity of Organs for Transplantation. (LivermanCT, DomnitzS, ChildressJF. eds.) National Academies Press: Washington, DC; 2017.
9.
National Conference of Commissioners on Uniform State Laws. Uniform Declaration of Death Act. United States; 1980.
10.
Judicial Counsel of the AMA. Ethical guidelines for organ transplantation. JAMA1968;205(6):341–342.
11.
BoylanHC, GoffAD. Dual advocates in deceased organ donation: The potential for moral distress in organ procurement organization staff. J Clin Ethics2024;35(1):70–75.
12.
Code of Federal Regulations. Condition of participation: Organ, tissue, and eye procurement. 1998.
13.
Healthcare and Human Services Administration HCFA. Medicare and Medicaid programs; hospital conditions of participation; identification of potential organ, tissue, and eye donors and transplant hospitals’ provision of transplant-related data. 1998.
14.
Organ Procurement and Transplantation Network. OPTN policies: Conflicts of interest. 2025.
15.
Health Resources and Services Administration. Learn about donation. HRSA; 2021. Available from: https://www.organdonor.gov/learn
16.
The Organ Donation Alliance. DCD Educational Guide. (LebovitzD. ed.) The Organ Donation Alliance; 2024.
17.
President’s commission for the study of ethical problems in medicine and biomedical and behavioral research. Defining Death: A Report on the Medical, Legal and Ethical Issues in the Determination of Death. The Commission; 1981.
18.
BielS, DurrantJ. Controversies in brain death declaration: Legal and ethical implications in the ICU. Curr Treat Options Neurol2020;22(4):12.
19.
GreerDM, KirschenMP, LewisA, et al.Pediatric and adult brain death/death by neurologic criteria consensus guideline: Report of the AAN guidelines subcommittee, AAP, CNS, and SCCM. Neurology2023;101(24):1112–1132.
20.
HobeikaMJ, MenserT, NguyenDT, et al.United States donation after circulatory death liver transplantation is driven by a few high-utilization transplant centers. Am J Transplant2020;20(1):320–321.
21.
KharawalaA, NagrajS, SeoJ, et al.Donation after circulatory death heart transplant: Current state and future directions. Circ Heart Fail2024;17(7):e011678.
22.
HausteinSV, SellersMT. Factors associated with (un) willingness to be an organ donor: Importance of public exposure and knowledge. Clin Transplant2004;18(2):193–200.
23.
U.S. Department of Health and Human Services Health Resources and Services Administration. National Survey of Organ Donation Attitudes and Practices, 2019: Report of Findings. Health Resources and Services Administration; 2019.
24.
OttM, MurphyN, LingardL, et al.Sowing “seeds of trust”: How trust in normothermic regional perfusion is built in a continuum of care. Am J Transplant2024;24(11):2045–2054.
25.
WallA, DuJ, ParentB, et al.Public perceptions of organ donation by determination of death and procurement technique. Am J Transplant2025;25(1):S5–S6.
Martínez-LópezMV, McLaughlinL, Molina-PérezA, et al.Mapping trust relationships in organ donation and transplantation: A conceptual model. BMC Med Ethics2023;24(1):93.
BenedictJL. Make it plain: Strengthening the ethical foundation of first-person authorization for organ donation. J Clin Ethics2017;28(4):303–307.
30.
SiminoffLA, AgyemangAA, TrainoHM. Consent to organ donation: A review. Prog Transplant2013;23(1):99–104.
31.
IltisAS, DennyB. First-person authorization and family objections to organ donation. J Med Philos2025;50(3):212–224.
32.
CallisonK, LevinA. Donor registries, first-person consent legislation, and the supply of deceased organ donors. J Health Econ2016;49:70–75.
33.
ChonWJ, JosephsonMA, GordonEJ, et al.When the living and the deceased cannot agree on organ donation: A survey of US Organ Procurement Organizations (OPOs). Am J Transplant2014;14(1):172–177.
34.
MiñambresE, SuberviolaB, Dominguez-GilB, et al.Improving the outcomes of organs obtained from controlled donation after circulatory death donors using abdominal normothermic regional perfusion. Am J Transplant2017;17(8):2165–2172.
35.
HessheimerAJ, de la RosaG, GastacaM, et al.Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss. Am J Transplant2022;22(4):1169–1181.
36.
TruogRD, FlescherA, LadinK. Normothermic regional perfusion—The next frontier in organ transplants? JAMA2023;329(24):2123–2124.
37.
SellersMT, PhilipJL, BrubakerAL, et al.Normothermic regional perfusion experience of organ procurement organizations in the US. JAMA Netw Open2024;7(10):e2440130.
38.
MagnusD. Resuscitating the dead: NRP and language. Am J Bioeth2024;24(6):1–3.
39.
Royo-VillanovaM, MiñambresE, SánchezJM, et al.Maintaining the permanence principle of death during normothermic regional perfusion in controlled donation after the circulatory determination of death: Results of a prospective clinical study. Am J Transplant2024;24(2):213–221.
40.
LarsonS, RyanJ, McKeeK, et al.333.9: Development of revised triggers for timely donation referral. Transplantation2019;103(11S):S90.
41.
PrommerE. Organ donation and palliative care: Can palliative care make a difference? J Palliat Med2014;17(3):368–371.
KelsoCM, LyckholmLJ, CoynePJ, et al.Palliative care consultation in the process of organ donation after cardiac death. J Palliat Med2007;10(1):118–126.
44.
ChanJD, TreecePD, EngelbergRA, et al.Narcotic and benzodiazepine use after withdrawal of life support: Association with time to death? Chest2004;126(1):286–293.
45.
HealeyA, HartwickM, DownarJ, et al.; for Canadian Blood Services, the Canadian Critical Care Society, the Canadian Association of Critical Care Nurses, and the Canadian Society of Palliative Care Physicians. Improving quality of withdrawal of life-sustaining measures in organ donation: A framework and implementation toolkit. Can J Anaesth2020;67(11):1549–1556.
46.
CappucciSP, SmithWS, SchwartzsteinR, et al.End-of-life care in the potential donor after circulatory death: A systematic review. Neurohospitalist2023;13(1):61–68.
47.
MazzuMA, CampbellML, SchwartzsteinRM, et al.Evidence guiding withdrawal of mechanical ventilation at the end of life: A review. J Pain Symptom Manage2023;66(3):e399–e426.
48.
CampbellML, TemplinT, WalchJ. A respiratory distress observation scale for patients unable to self-report dyspnea. J Palliat Med2010;13(3):285–290.
49.
OdhnerM, WegmanD, FreelandN, et al.Assessing pain control in nonverbal critically ill adults. Dimens Crit Care Nurs2003;22(6):260–267.
50.
SesslerCN, GosnellMS, GrapMJ, et al.The Richmond agitation–sedation scale: Validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med2002;166(10):1338–1344.
51.
FehnelCR, de la HozMA, CeliLA, et al.Incidence and risk model development for severe tachypnea following terminal extubation. Chest2020;158(4):1456–1463.
52.
ScaleaJR, RedfieldRR, RizzariMD, et al.When do DCD donors die?: Outcomes and implications of DCD at a high-volume, single-center OPO in the United States. Ann Surg2016;263(2):211–216.
53.
TaylorLJ, BuffingtonA, ScaleaJR, et al.Harms of unsuccessful donation after circulatory death: An exploratory study. Am J Transplant2018;18(2):402–409.
54.
National Hospice and Palliative Care Organization. Compliance tools and resources. 2022.
55.
Nikbakht NasrabadiA, WibisonoAH, AllenK-A, et al.Exploring the experiences of nurses’ moral distress in long-term care of older adults: A phenomenological study. BMC Nurs2021;20(1):156.
